Innovation Pharmaceuticals Inc (IPIX)

[StockJumper25]

An update on that DEX study from the European Study review.

Timeline for perspective, it took nearly 60 days to complete. It included 11,000 patients.

It proved better support than what Remdesivier offers.

It just needs to be paired with a better treatment option for patient therapy (Like Brilacidin, maybe).

https://www.europeanpharmaceuticalreview.com/news/121237/dexamethasone-reduces-covid-19-patient-deaths-by-one-third/

(No use for Hydroxychloroquin)
Wish that BP would immediately put it from use and stop promoting.

Hydroxychloroquine has no benefit to patients hospitalised with COVID-19, finds trial.
https://www.europeanpharmaceuticalreview.com/news/120856/hydroxychloroquine-has-no-benefit-to-patients-hospitalised-with-covid-19-finds-trial/